Q5118 Inj., zirabev, 10 mg

Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 230 units per day (practitioner), rationale: CMS Policy